Search results
The Best Products For Treating Psoriasis, According To Dermatologists
HuffPost· 4 days agoLa Roche-Posay triple repair body cream, CeraVe psoriasis cream and scalp psoriasis shampoo and...
Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
FierceBiotech· 6 days agoSpecifically, Alumis plans to use part of the IPO haul to advance the development of its lead asset,...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 4 days agoTapinarof is an aryl hydrocarbon receptor (AhR) receptor modulator that has been observed to have...
Biogen Inc. (NASDAQ:BIIB) Shares Bought by FIL Ltd
ETF DAILY NEWS· 21 hours agoFIL Ltd raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 936.4% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 656,502 shares of ...
AbbVie (NYSE:ABBV) Shares Up 0%
ETF DAILY NEWS· 17 hours agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0% during mid-day trading on Thursday . The company traded as high as $166.45 and last traded at $166.15. ABBV has been the topic ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.
ETF DAILY NEWS· 18 hours agoGarde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm ...
Alvotech (NASDAQ:ALVO) Short Interest Update
ETF DAILY NEWS· 2 days agoAlvotech (NASDAQ:ALVO – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 93,900 shares, a drop ...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 6 days agoAlumis’ offering will help support Phase 3 trials of a drug it claims could be a challenger to...
Roflumilast cream shows promise for long-term AD control By Investing.com
Investing.com· 5 days agoArcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company, announced...
Cresset Asset Management LLC Lowers Position in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoCresset Asset Management LLC cut its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
